RASAGILINE MESYLATE vs ROPINIROLE HYDROCHLORIDE

Compare RASAGILINE MESYLATE (Rasagiline) and ROPINIROLE HYDROCHLORIDE (ROPINIROLE HYDROCHLORIDE) — clinical data, side effects, and patient experiences.

RASAGILINE MESYLATE

Rasagiline · Parkinson's Agent

How it works

12.1 Mechanism of Action Rasagiline is a selective, irreversible MAO-B inhibitor indicated for the treatment of idiopathic Parkinson’s disease. The results of a clinical trial desi...

Approved for

1 INDICATIONS AND USAGE Rasagiline tablets are indicated for the treatment of Parkinson’s disease (PD). Rasagiline

a monoamine oxidase (MAO)-B inhibitor (MAOI)

is indicated for the treatment of Parkinson’s disease (1)

OralTablet

ROPINIROLE HYDROCHLORIDE

ROPINIROLE HYDROCHLORIDE · Parkinson's Agent

How it works

12.1 Mechanism of Action Ropinirole is a non-ergoline dopamine agonist. The precise mechanism of action of ropinirole as a treatment for Parkinson’s disease is unknown, although it...

Approved for

See full prescribing information

OralTablet

Quick Comparison

RASAGILINE MESYLATEROPINIROLE HYDROCHLORIDE

Drug Class

Parkinson's Agent

Route

Oral

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

RASAGILINE MESYLATE

Falls

>10%

Drug Not Working

1-10%

Tremor

1-10%

Dizziness

1-10%

Drowsiness

1-10%

Nausea

1-10%

Fatigue

1-10%

Constipation

0.1-1%

ROPINIROLE HYDROCHLORIDE

Drug Not Working

>10%

Falls

1-10%

Fatigue

1-10%

Nausea

1-10%

Dizziness

1-10%

Shortness of Breath

1-10%

Diarrhea

1-10%

Weakness

1-10%

FDA Warnings

RASAGILINE MESYLATE

5 WARNINGS AND PRECAUTIONS May cause hypertension (including severe hypertensive syndromes) at recommended doses ( 5
When used as an adjunct to levodopa (Studies 3 and 4), the risk for developing post-treatment high blood pressure (e
Rasagiline is contraindicated for use with meperidine, tramadol, methadone, propoxyphene, and MAO inhibitors (MAOIs), including other selective MAO-B inhibitors [see Contraindications ( 4 ) and Drug Interactions ( 7
Serotonin syndrome can result in death

ROPINIROLE HYDROCHLORIDE

5 WARNINGS AND PRECAUTIONS · Sudden onset of sleep and somnolence may occur (5
Although many of these patients reported somnolence while on ropinirole tablets, some perceived that they had no warning signs, such as excessive drowsiness, and believed that they were alert immediately prior to the event
Before initiating treatment with ropinirole tablets, patients should be advised of the potential to develop drowsiness and specifically asked about factors that may increase the risk with ropinirole tablets such as concomitant sedating medications or alcohol, the presence of sleep disorders (other than RLS), and concomitant medications that increase ropinirole plasma levels (e
Patients on ropinirole tablets should be monitored for signs and symptoms of orthostatic hypotension, especially during dose escalation, and should be informed of the risk for syncope and hypotension [see Patient Counseling Information (17)]

Clinical Trial Data

No head-to-head clinical studies found for RASAGILINE MESYLATE vs ROPINIROLE HYDROCHLORIDE.

RASAGILINE MESYLATE vs ROPINIROLE HYDROCHLORIDE: What You Should Know

Key Differences

Both RASAGILINE MESYLATE and ROPINIROLE HYDROCHLORIDE belong to the Parkinson's Agent class. While they share a similar mechanism of action, differences in pharmacokinetics, dosing, and side effect profiles may make one more suitable than the other for individual patients.

Safety Considerations

RASAGILINE MESYLATE carries 4 FDA warnings. ROPINIROLE HYDROCHLORIDE carries 4 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.

Related Comparisons

PRAMIPEXOLE DIHYDROCHLORIDE vs ROPINIROLE HYDROCHLORIDE→ENTACAPONE vs ROPINIROLE HYDROCHLORIDE→RASAGILINE vs ROPINIROLE HYDROCHLORIDE→CARBIDOPA AND LEVODOPA vs ROPINIROLE HYDROCHLORIDE→LEVODOPA vs ROPINIROLE HYDROCHLORIDE→ROPINIROLE vs ROPINIROLE HYDROCHLORIDE→

Loading comparison data...

RASAGILINE MESYLATE vs ROPINIROLE HYDROCHLORIDE

Compare RASAGILINE MESYLATE (Rasagiline) and ROPINIROLE HYDROCHLORIDE (ROPINIROLE HYDROCHLORIDE) — clinical data, side effects, and patient experiences.

RASAGILINE MESYLATE

Rasagiline · Parkinson's Agent

How it works

12.1 Mechanism of Action Rasagiline is a selective, irreversible MAO-B inhibitor indicated for the treatment of idiopathic Parkinson’s disease. The results of a clinical trial desi...

Approved for

1 INDICATIONS AND USAGE Rasagiline tablets are indicated for the treatment of Parkinson’s disease (PD). Rasagiline

a monoamine oxidase (MAO)-B inhibitor (MAOI)

is indicated for the treatment of Parkinson’s disease (1)

OralTablet

ROPINIROLE HYDROCHLORIDE

ROPINIROLE HYDROCHLORIDE · Parkinson's Agent

How it works

12.1 Mechanism of Action Ropinirole is a non-ergoline dopamine agonist. The precise mechanism of action of ropinirole as a treatment for Parkinson’s disease is unknown, although it...

Approved for

See full prescribing information

OralTablet

Quick Comparison

RASAGILINE MESYLATEROPINIROLE HYDROCHLORIDE

Drug Class

Parkinson's Agent

Route

Oral

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

RASAGILINE MESYLATE

Falls

>10%

Drug Not Working

1-10%

Tremor

1-10%

Dizziness

1-10%

Drowsiness

1-10%

Nausea

1-10%

Fatigue

1-10%

Constipation

0.1-1%

ROPINIROLE HYDROCHLORIDE

Drug Not Working

>10%

Falls

1-10%

Fatigue

1-10%

Nausea

1-10%

Dizziness

1-10%

Shortness of Breath

1-10%

Diarrhea

1-10%

Weakness

1-10%

FDA Warnings

RASAGILINE MESYLATE

5 WARNINGS AND PRECAUTIONS May cause hypertension (including severe hypertensive syndromes) at recommended doses ( 5
When used as an adjunct to levodopa (Studies 3 and 4), the risk for developing post-treatment high blood pressure (e
Rasagiline is contraindicated for use with meperidine, tramadol, methadone, propoxyphene, and MAO inhibitors (MAOIs), including other selective MAO-B inhibitors [see Contraindications ( 4 ) and Drug Interactions ( 7
Serotonin syndrome can result in death

ROPINIROLE HYDROCHLORIDE

5 WARNINGS AND PRECAUTIONS · Sudden onset of sleep and somnolence may occur (5
Although many of these patients reported somnolence while on ropinirole tablets, some perceived that they had no warning signs, such as excessive drowsiness, and believed that they were alert immediately prior to the event
Before initiating treatment with ropinirole tablets, patients should be advised of the potential to develop drowsiness and specifically asked about factors that may increase the risk with ropinirole tablets such as concomitant sedating medications or alcohol, the presence of sleep disorders (other than RLS), and concomitant medications that increase ropinirole plasma levels (e
Patients on ropinirole tablets should be monitored for signs and symptoms of orthostatic hypotension, especially during dose escalation, and should be informed of the risk for syncope and hypotension [see Patient Counseling Information (17)]

Clinical Trial Data

No head-to-head clinical studies found for RASAGILINE MESYLATE vs ROPINIROLE HYDROCHLORIDE.

RASAGILINE MESYLATE vs ROPINIROLE HYDROCHLORIDE: What You Should Know

Key Differences

Safety Considerations

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.